4.2 Article

Sars-CoV-2 Envelope and Membrane Proteins: Structural Differences Linked to Virus Characteristics?

Journal

BIOMED RESEARCH INTERNATIONAL
Volume 2020, Issue -, Pages -

Publisher

HINDAWI LTD
DOI: 10.1155/2020/4389089

Keywords

-

Funding

  1. Sapienza University of Rome [RP11916B74B27C4D]

Ask authors/readers for more resources

The Coronavirus Disease 2019 (COVID-19) is a new viral infection caused by the severe acute respiratory coronavirus 2 (SARS-CoV-2). Genomic analyses have revealed that SARS-CoV-2 is related to Pangolin and Bat coronaviruses. In this report, a structural comparison between the Sars-CoV-2 Envelope and Membrane proteins from different human isolates with homologous proteins from closely related viruses is described. The analyses here reported show the high structural similarity of Envelope and Membrane proteins to the counterparts from Pangolin and Bat coronavirus isolates. However, the comparisons have also highlighted structural differences specific of Sars-CoV-2 proteins which may be correlated to the cross-species transmission and/or to the properties of the virus. Structural modelling has been applied to map the variant sites onto the predicted three-dimensional structure of the Envelope and Membrane proteins.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Letter Infectious Diseases

Peculiar Variations of the Electrostatic Potential of Spike Protein N-terminal Domain Associated with the Emergence of Successive SARS-CoV-2 Omicron Lineages

Stefano Pascarella, Massimo Ciccozzi, Domenico Benvenuto, Alessandra Borsetti, Roberto Cauda, Antonio Cassone

JOURNAL OF INFECTION (2023)

Letter Hematology

Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment

Domenico Benvenuto, Sergio Carnevale, Marta Giovanetti, Massimo Ciccozzi, Francesco Broccolo

SEMINARS IN THROMBOSIS AND HEMOSTASIS (2023)

Letter Virology

On the SARS-CoV-2 BA.2.75 variant: A genetic and structural point of view

Fabio Scarpa, Daria Sanna, Ilenia Azzena, Marta Giovanetti, Domenico Benvenuto, Silvia Angeletti, Giancarlo Ceccarelli, Stefano Pascarella, Marco Casu, Pier Luigi Fiori, Massimo Ciccozzi

JOURNAL OF MEDICAL VIROLOGY (2023)

Letter Virology

SARS-CoV-2 pandemic, influenza, and influenza-like illness epidemics: Allies or enemies?

Giancarlo Ceccarelli, Gabriele d'Ettorre, Alessandro Russo, Silvia Fabris, Massimo Ciccozzi, Gabriella d'Ettorre

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Virology

Short-term forecasts of Monkeypox cases in multiple countries: keep calm and don't panic

Marco Mingione, Massimo Ciccozzi, Marco Falcone, Antonello Maruotti

Summary: A parametric regression model using the Richards' curve was proposed to analyze the incidence indicators of Monkeypox in the top 10 affected countries worldwide. Current results indicate that the outbreak is under control in most countries.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Medicine, General & Internal

Functional Benefit of Smoking Cessation and Triple Inhaler in Combustible Cigarette Smokers with Severe COPD: A Retrospective Study

Aldo Pezzuto, Giuseppe Tonini, Massimo Ciccozzi, Pierfilippo Crucitti, Michela D'Ascanio, Fiammetta Cosci, Antonella Tammaro, Antonella Di Sotto, Teresa Palermo, Elisabetta Carico, Alberto Ricci

Summary: The aim of this study was to determine the benefits of smoking cessation combined with a single inhaler triple therapy in patients with COPD. The study found that 51% of patients successfully quit smoking within a month, and these patients showed better outcomes after six months compared to those who continued smoking, including improvements in lung function and physical activity.

JOURNAL OF CLINICAL MEDICINE (2023)

Editorial Material Virology

Two sides of the same coin: the N-terminal and the receptor binding domains of SARS-CoV-2 Spike

Massimo Ciccozzi, Stefano Pascarella

Summary: The Spike receptor binding domain and N-terminal domain of SARS-CoV-2 interact with each other through a complex mechanism. Genetic mutations affect the interplay between the Spike protein and host molecules. This editorial discusses the intricacies of SARS-CoV-2 Spike interactions.

FUTURE VIROLOGY (2023)

Letter Infectious Diseases

Genetic and structural genome-based survey reveals the low potential for epidemiological expansion of the SARS-CoV-2 XBB.1.5 sublineage

Fabio Scarpa, Elena Imperia, Ilenia Azzena, Marta Giovanetti, Domenico Benvenuto, Chiara Locci, Marco Casu, Pier Luigi Fiori, Antonello Maruotti, Giancarlo Ceccarelli, Alessandra Borsetti, Arnaldo Caruso, Roberto Cauda, Antonio Cassone, Allegra Via, Stefano Pascarella, Daria Sanna, Massimo Ciccozzi

JOURNAL OF INFECTION (2023)

Review Biochemistry & Molecular Biology

HIV-1-Host Interaction in Gut-Associated Lymphoid Tissue (GALT): Effects on Local Environment and Comorbidities

Sonia Moretti, Ivan Schietroma, Giuseppe Sberna, Maria Teresa Maggiorella, Leonardo Sernicola, Stefania Farcomeni, Marta Giovanetti, Massimo Ciccozzi, Alessandra Borsetti

Summary: HIV-1 replication in the gastrointestinal tract causes CD4+ T-cell depletion and disruption of the intestinal mucosa, leading to microbial translocation, inflammation, and immune activation. The gut serves as a viral reservoir with higher levels of HIV DNA compared to the blood. The interaction between HIV and key subsets of CD4+ T cells in the gut, as well as the role of gut microbiome and its metabolites in HIV-associated inflammation and immune activation, are important in the pathogenesis of HIV infection and related comorbidities.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Biochemistry & Molecular Biology

Integrative Genome-Based Survey of the SARS-CoV-2 Omicron XBB.1.16 Variant

Fabio Scarpa, Ilenia Azzena, Alessandra Ciccozzi, Marta Giovanetti, Chiara Locci, Marco Casu, Pier Luigi Fiori, Alessandra Borsetti, Eleonora Cella, Miriana Quaranta, Stefano Pascarella, Daria Sanna, Massimo Ciccozzi, Igor Rogozin

Summary: The XBB.1.16 variant of SARS-CoV-2 has the potential to evade immune response but its evolutionary rate is slower than dangerous lineages. Structural analysis shows no significant differences from previous lineages, indicating no exceptional danger or high expansion capability. Continuous genome-based monitoring is important for understanding its descendants and other lineages.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Review Virology

Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2

Marta Giovanetti, Francesco Branda, Eleonora Cella, Fabio Scarpa, Liliana Bazzani, Alessandra Ciccozzi, Svetoslav Nanev Slavov, Domenico Benvenuto, Daria Sanna, Marco Casu, Luciane Amorim Santos, Alessia Lai, Giangluglielmo Zehender, Francesca Caccuri, Andrea Ianni, Arnaldo Caruso, Antonello Maroutti, Stefano Pascarella, Alessandra Borsetti, Massimo Ciccozzi

Summary: This comprehensive review focuses on the impact of SARS-CoV-2 as the cause of the COVID-19 pandemic. It covers the virus's epidemic history, evolutionary aspects, and implications for public health. The review emphasizes the importance of genomic surveillance in tracking viral mutations and implementing public health interventions.

JOURNAL OF MEDICAL VIROLOGY (2023)

Article Microbiology

SARS-CoV-2 Recombinants: Genomic Comparison between XBF and Its Parental Lineages

Fabio Scarpa, Chiara Locci, Ilenia Azzena, Marco Casu, Pier Luigi Fiori, Alessandra Ciccozzi, Marta Giovanetti, Miriana Quaranta, Giancarlo Ceccarelli, Stefano Pascarella, Massimo Ciccozzi, Daria Sanna

Summary: Recombination events are common in RNA viruses and the XBF SARS-CoV-2 lineage is a recent recombinant during the COVID-19 pandemic. Genetic analyses show that XBF does not have significant expansion potential or a higher contagion rate compared to other lineages. Cautionary measures should still be taken and genome-based monitoring remains important for detecting changes in viral genome composition.

MICROORGANISMS (2023)

Article Microbiology

Early Detection of the Recombinant SARS-CoV-2 XAN Variant in Bulgaria: Initial Genomic Insights into Yet Another Piece of the Growing Puzzle of Recombinant Clades

Ivailo Alexiev, Ivan Ivanov, Marta Giovanetti, Eleonora Cella, Ivan Stoikov, Deyan Donchev, Lyubomira Grigorova, Anna Gancheva, Reneta Dimitrova, Fabio Scarpa, Neli Korsun, Ivelina Trifonova, Veselin Dobrinov, Todor Kantardjiev, Iva Christova, Massimo Ciccozzi

Summary: The first recombinant SARS-CoV-2 variants were identified in 2022, causing public health concerns. The importance of recombinant variants has increased especially since the WHO designated the recombinant variant XBB and its lineages as subvariants that require monitoring on 20 November 2022. In this study, we provide the first insights into the new SARS-CoV-2 variant named XAN, a recombinant composed of Omicron sub-lineages BA.2 and BA.5. To our knowledge, this is the first report on the recombinant SARS-CoV-2 XAN variant identified in Bulgaria.

MICROORGANISMS (2023)

Review Microbiology

Monitoring Monkeypox: Safeguarding Global Health through Rapid Response and Global Surveillance

Marta Giovanetti, Eleonora Cella, Sonia Moretti, Fabio Scarpa, Alessandra Ciccozzi, Svetoslav Nanev Slavov, Francesca Benedetti, Davide Zella, Giancarlo Ceccarelli, Massimo Ciccozzi, Alessandra Borsetti

Summary: Monkeypox has emerged as a significant global threat, highlighting the importance of global monitoring and rapid response. The unpredictable nature of its transmission, potential for human-to-human spread, and high morbidity rate underscore the need for proactive surveillance and international collaboration.

PATHOGENS (2023)

Review Microbiology

Joining Forces against Antibiotic Resistance: The One Health Solution

Eleonora Cella, Marta Giovanetti, Francesca Benedetti, Fabio Scarpa, Catherine Johnston, Alessandra Borsetti, Giancarlo Ceccarelli, Taj Azarian, Davide Zella, Massimo Ciccozzi

Summary: Antibiotic resistance is a significant global health concern that requires a collaborative One Health approach. It poses a threat to human and animal health, as well as the effectiveness of medical treatments and veterinary interventions.

PATHOGENS (2023)

No Data Available